Raymond James Financial
TMCI icon

Raymond James Financial’s Treace Medical Concepts TMCI Stock Holding History

Raymond James Financial’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$479K Buy
357,556
+34,614
+11% +$69K ﹤0.01% 4373
2025
Q4 		$791K Buy
322,942
+288,141
+828% +$1.25M ﹤0.01% 3940
2025
Q3 		$234K Sell
34,801
-13,859
-28% -$90.5K ﹤0.01% 4539
2025
Q2 		$286K Sell
48,660
-26,215
-35% -$171K ﹤0.01% 4315
2025
Q1 		$628K Buy
74,875
+22,133
+42% +$199K ﹤0.01% 3787
2024
Q4 		$392K Buy
+52,742
New +$353K ﹤0.01% 4041

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's TMCI Position: Q1 2026 in Review

Raymond James Financial increased its Treace Medical Concepts (TMCI) stake by 11% in Q1 2026, buying an estimated $69K and bringing the position to 357,556 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #4373.

Raymond James Financial first reported a position in TMCI in Q4 2024 and has held it in 6 quarters since. The position peaked at $791K in Q4 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Raymond James Financial held 357,556 shares of Treace Medical Concepts worth $479K as of Q1 2026.
  • Raymond James Financial bought 34,614 Treace Medical Concepts shares in Q1 2026, an estimated $69K.
  • Treace Medical Concepts made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4373 holding.
  • Raymond James Financial first reported a position in Treace Medical Concepts in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Treace Medical Concepts position peaked at $791K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.